J. Raymond, A. Fargin, M. Lohse, J. Regan, S. Senogles, R. Lefkowitz, and M. Caron. Mol Pharmacol, 36 (1):
15-21(July 1989)Raymond, J R Fargin, A Lohse, M J Regan, J W Senogles, S E Lefkowitz,
R J Caron, M G HL-16037/HL/NHLBI NIH HHS/United States NS-19576/NS/NINDS
NIH HHS/United States S07-RR-05405/RR/NCRR NIH HHS/United States
Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
United states Molecular pharmacology Mol Pharmacol. 1989 Jul;36(1):15-21..
D. Martens, M. Lohse, B. Rauch, and U. Schwabe. Naunyn Schmiedebergs Arch Pharmacol, 336 (3):
342-8(September 1987)Martens, D Lohse, M J Rauch, B Schwabe, U In Vitro Research Support,
Non-U.S. Gov't Germany, west Naunyn-Schmiedeberg's archives of pharmacology
Naunyn Schmiedebergs Arch Pharmacol. 1987 Sep;336(3):342-8..
M. Lohse, D. Ukena, and U. Schwabe. Naunyn Schmiedebergs Arch Pharmacol, 328 (3):
310-6(January 1985)Lohse, M J Ukena, D Schwabe, U In Vitro Germany, west Naunyn-Schmiedeberg's
archives of pharmacology Naunyn Schmiedebergs Arch Pharmacol. 1985
Jan;328(3):310-6..
A. Gabilondo, C. Krasel, and M. Lohse. Eur J Pharmacol, 307 (2):
243-50(June 1996)Gabilondo, A M Krasel, C Lohse, M J Research Support, Non-U.S. Gov't
Netherlands European journal of pharmacology Eur J Pharmacol. 1996
Jun 27;307(2):243-50..